WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Patent Owner
Stats
- 14 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Feb 27, 2018 most recent publication
Details
- 14 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 86 Total Citation Count
- Apr 14, 2005 Earliest Filing
- 17 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0138,931 METHOD FOR DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN CApr 13, 09May 18, 17[A61K, A61P]
2016/0289,270 Methods, Peptides and Antibodies for Preventing, Treating and Diagnosing an Inflammatory ConditionNov 17, 14Oct 06, 16[G01N, C07K]
2016/0158,322 NDP-MSH FOR TREATMENT OF INFLAMMATORY AND/OR NEURODEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEMAug 05, 14Jun 09, 16[A61K]
2015/0210,768 Methods and Compounds for Preventing, Treating and Diagnosing an Inflammatory ConditionSep 10, 13Jul 30, 15[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9905885 1,2,4-thiadiazinane-3,5-dione-1,1-dioxide derivatives, production and use thereofApr 25, 13Feb 27, 18[H01M, C07D]
9808203 Method for motion correction of emission computed tomography data by way of magnetic resonance tomography dataMay 20, 14Nov 07, 17[G06T, A61B, G01R]
9637523 Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated diseaseAug 30, 13May 02, 17[A61K, C12Q, C12N, G01N, A61P, C07K]
9412574 Parallel elemental and molecular mass spectrometry analysis with laser ablation samplingJan 28, 14Aug 09, 16[H01J, B01D]
9345791 Ligands for targeting of S1P receptors for in vivo imaging and treatment of diseasesAug 16, 12May 24, 16[A61K, C07D, C07C]
8980845 Biotechnological production of cyanophycin dipeptidesJun 15, 09Mar 17, 15[A61K, C12P, A23L, C12N, A23K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0357,173 LASER ABLATION ATMOSPHERIC PRESSURE IONIZATION MASS SPECTROMETRYAbandonedJan 28, 14Dec 10, 15[H01J]
2015/0308,939 ASSESSMENT OF RISK OF HYPERTENSION AND METHODS BASED THEREONAbandonedNov 26, 13Oct 29, 15[G01N]
2015/0105,278 METHODS OR RISK ASSESSMENT OF PML AND RELATED APPARATUSAbandonedOct 16, 12Apr 16, 15[C12Q, G01N]
2015/0072,898 Broad Host Range Expression Vector for Diverse ProkaryotesAbandonedSep 11, 14Mar 12, 15[C12N]
2014/0199,402 NOVEL COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASEAbandonedAug 09, 12Jul 17, 14[A61K, A23L, C12N]
2013/0252,959 NITRIC OXIDE DONORS IN THERAPY OF NITRIC OXIDE DEFICIENCY-INDUCED DISTURBANCES OF CEREBRAL MICROCIRCULATIONAbandonedNov 25, 11Sep 26, 13[C07D]
2012/0036,600 METHOD FOR GENERATING HYPOALLERGENIC GLYCOPROTEINS IN MUTATED OR TRANSGENIC PLANTS OR PLANT CELLS, AND MUTATED OR TRANSGENIC PLANTS AND PLANT CELLS FOR GENERATING HYPOALLERGENIC GLYCOPROTEINSAbandonedApr 25, 09Feb 09, 12[C12P, C12N, A01H, C07K]
2011/0225,663 METHOD FOR PRODUCING EUKARYOTIC ORGANISMS WITH ENHANCED PATHOGEN RESISTANCE AND/OR RESISTANCE TO STRESS AND EUKARYOTIC TRANSGENIC ORGANISMS WITH ENHANCED PATHOGEN RESISTANCE AND/OR RESISTANCE TO STRESSAbandonedSep 04, 09Sep 15, 11[C12N, A01K, A01H]
2008/0278,573 Method and Arrangement for Monoscopically Representing at Least One Area of an Image on an Autostereoscopic Display Apparatus and Information Reproduction Unit Having Such an ArrangementAbandonedNov 14, 06Nov 13, 08[H04N]
2006/0233,309 Laser x-ray source apparatus and target used thereforeAbandonedApr 14, 05Oct 19, 06[H01J]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.